UBS Group AG - ADICET BIO INC ownership

ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 104 filers reported holding ADICET BIO INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ADICET BIO INC
ValueSharesWeighting
Q3 2023$5,942
+8903.0%
4,337
+15963.0%
0.00%
Q2 2023$66
-100.0%
27
-100.0%
0.00%
Q4 2022$1,051,246
+327.3%
117,589
+580.9%
0.00%
Q3 2022$246,000
+2136.4%
17,269
+3057.0%
0.00%
Q1 2022$11,000
-93.6%
547
-94.5%
0.00%
Q4 2021$173,000
+17200.0%
9,885
+6403.3%
0.00%
Q3 2021$1,000
-95.5%
152
-91.0%
0.00%
Q1 2021$22,000
+175.0%
1,693
+194.9%
0.00%
Q4 2020$8,000
-52.9%
574
-59.0%
0.00%
Q3 2020$17,0001,4000.00%
Other shareholders
ADICET BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Abingworth LLP 1,615,385$20,968,0007.24%
Consonance Capital Management LP 1,216,860$15,917,0001.70%
VR Adviser, LLC 1,000,000$13,080,0001.42%
Johnson & Johnson Innovation - JJDC, Inc. 728,944$9,535,0001.24%
DAFNA Capital Management LLC 385,077$5,037,0001.20%
Ally Bridge Group (NY) LLC 425,000$5,559,0001.07%
Orbimed Advisors 7,232,856$94,606,0000.88%
Avidity Partners Management LP 2,230,000$29,168,0000.81%
Altium Capital Management LP 142,289$1,861,0000.52%
Nantahala Capital Management 395,875$5,178,0000.15%
View complete list of ADICET BIO INC shareholders